Skip to main content

Peer Review reports

From: Comparing different dosing regimens of bevacizumab in the treatment of neovascular macular degeneration: study protocol for a randomised controlled trial

Original Submission
8 Sep 2014 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
16 Feb 2015 Editorially accepted
10 Mar 2015 Article published 10.1186/s13063-015-0608-2

You can find further information about peer review here.

Back to article page

Trials

ISSN: 1745-6215